Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia A and B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02190149
What this trial is testing

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 64
Testing effectiveness (Phase 2)Study completedNCT05619926
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 32
Not applicableStudy completedNCT01959555
What this trial is testing

Project to Update the Study of Congenital Haemophilia in Spain

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 1,157
Early research (Phase 1)Study completedNCT02418793
What this trial is testing

A Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
OPKO Health, Inc. 27
Large-scale testing (Phase 3)Study completedNCT04580407
What this trial is testing

Study of TAK-672 in Participants With Acquired Hemophilia A

Who this might be right for
Acquired Hemophilia A
Takeda 5
Early research (Phase 1)Ended earlyNCT01620801
What this trial is testing

Hemophilia B Gene Therapy With AAV8 Vector

Who this might be right for
Hemophilia B
Spark Therapeutics, Inc. 4
Not applicableEnrolling By InvitationNCT06831734
What this trial is testing

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Who this might be right for
Haemophilia A, Haemophilia B
Novo Nordisk A/S 30
Not applicableStudy completedNCT00710619
What this trial is testing

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 52
Not applicableStudy completedNCT00927992
What this trial is testing

Study Evaluating Liver Transplantation in Haemophilia Patients in Spain

Who this might be right for
HemophiliaHemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 11
Early research (Phase 1)Study completedNCT01555749
What this trial is testing

Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 8
Testing effectiveness (Phase 2)Study completedNCT03715348
What this trial is testing

Trial of PCC Versus FFP in Patients Undergoing Heart Surgery

Who this might be right for
BleedingSurgeryTransfusion
Queen Mary University of London 50
Large-scale testing (Phase 3)Study completedNCT00038935
What this trial is testing

Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Large-scale testing (Phase 3)Study completedNCT01174446
What this trial is testing

Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 86
Early research (Phase 1)Study completedNCT00951873
What this trial is testing

A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 38
Post-approval studies (Phase 4)Ended earlyNCT04244981
What this trial is testing

Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery

Who this might be right for
Valvular Heart Surgery
SHI Jia 476
Not applicableStudy completedNCT05214300
What this trial is testing

Screening for Bleeding Disorders in Children

Who this might be right for
Bleeding Disorder
University Hospital, Montpellier 96
Early research (Phase 1)Study completedNCT00979238
What this trial is testing

Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B

Who this might be right for
Hemophilia B
St. Jude Children's Research Hospital 14
Early research (Phase 1)Study completedNCT03075670
What this trial is testing

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 15
Testing effectiveness (Phase 2)Study completedNCT03407651
What this trial is testing

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 11
Not applicableStudy completedNCT02971969
What this trial is testing

Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Ultragenyx Pharmaceutical Inc 6
Next Page